IRON(II)-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA
    3.
    发明申请
    IRON(II)-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA 审中-公开
    铁(II) - 治疗高磷血症

    公开(公告)号:WO2008005217A3

    公开(公告)日:2008-02-21

    申请号:PCT/US2007014688

    申请日:2007-06-25

    Abstract: A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Alternatively, a pharmaceutica composition comprises a pharmaceutically acceptable ferrous iron compound and pharmaceutically acceptable carrier, wherein the ferrous iron compound is selecte from the group consisting of iron(II) acetate, iron(II) citrate, iron(II) ascorbate, iron(II) oxalate, iron(II) oxide, iron(II) carbonate, iron(II) carbonate saccharated, iron(II) formate, iron(II) sulfate, iron(II) chloride, iron(II) acetylacetonate and combinations thereof. A method of treating a subject with hyperphosphatemia comprises administering to the subject an effective amount of a pharmaceutical composition as described above.

    Abstract translation: 药物组合物包含药学上可接受的亚铁化合物; 胺聚合物或其药学上可接受的盐和药学上可接受的载体。 或者,药物组合物包含药学上可接受的亚铁化合物和药学上可接受的载体,其中亚铁化合物选自乙酸铁(II),柠檬酸铁(II),抗坏血酸铁(II),抗坏血酸铁(II) )草酸盐,氧化铁(II),碳酸铁(II),糖化的碳酸铁(II),甲酸铁(II),硫酸铁(II),氯化铁(II),乙酰丙酮铁(II)及其组合。 治疗高磷血症患者的方法包括给予患者有效量的上述药物组合物。

    AMINE CONDENSATION POLYMERS AS PHOSPHATE SEQUESTRANTS
    4.
    发明申请
    AMINE CONDENSATION POLYMERS AS PHOSPHATE SEQUESTRANTS 审中-公开
    氨基聚合聚合物作为磷酸酯序列

    公开(公告)号:WO2007130463A2

    公开(公告)日:2007-11-15

    申请号:PCT/US2007/010650

    申请日:2007-05-02

    CPC classification number: A61K31/785 C08G73/02 C08G73/0206

    Abstract: Disclosed is a polymer or physiologically acceptable salt thereof. The polymer comprises a polymerized multifunctional amine monomer. The amine monomer comprises at least two amine groups and at least two acyclic nitrogen atoms that are connected through a -CH 2 CH 2 - group, provided that the amine monomer is not ethylenediamine or diethylenetriamine. The disclosed polymers can be used to bind anions in subject in need of such treatment.

    Abstract translation: 公开了一种聚合物或其生理上可接受的盐。 聚合物包含聚合的多官能胺单体。 胺单体包含至少两个胺基团和至少两个通过-CH 2 CH 2 - 基团连接的无环氮原子,条件是胺单体不是 乙二胺或二亚乙基三胺。 所公开的聚合物可用于结合需要这种治疗的受试者中的阴离子。

    POLYMERIC MOLECULAR RECEPTORS AS PHOSPHATE SEQUESTRANTS
    5.
    发明申请
    POLYMERIC MOLECULAR RECEPTORS AS PHOSPHATE SEQUESTRANTS 审中-公开
    聚合物分子受体作为磷酸酯序列

    公开(公告)号:WO2007027566A2

    公开(公告)日:2007-03-08

    申请号:PCT/US2006/033437

    申请日:2006-08-25

    Abstract: Polymers and compositions utilizing such polymers are disclosed for treating hyperphosphatemia and other illnesses associated with elevated serum phosphate levels. Phosphate binding polymers, or a pharmaceutically acceptable salt of the polymers, comprise pendent groups extending from a backbone of the polymer. Each pendent group comprises at least two nitrogen-bearing functional groups which bind phosphate. Variations of such polymer and compositions are disclosed.

    Abstract translation: 公开了使用这种聚合物的聚合物和组合物用于治疗与高血清磷酸盐水平升高相关的高磷酸盐血症和其它疾病。 磷酸酯结合聚合物或聚合物的药学上可接受的盐包括从聚合物主链延伸的侧基。 每个侧基包含至少两个结合磷酸盐的含氮官能团。 公开了这种聚合物和组合物的变化。

Patent Agency Ranking